Effects of antiepileptic drugs on the activation of glutamate receptors

Progress in Brain Research

Volumn 116, Issue , 1998, Pages 385-393

  Tauboll, E ^a   Gjerstad, L ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 2 AMINO 5 PHOSPHONOVALERIC ACID; 2 AMINO 7 PHOSPHONOHEPTANOIC ACID; 6 (1 IMIDAZOLYL) 7 NITRO 2,3 QUINOXALINEDIONE; AMPA RECEPTOR; ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; CARBAMAZEPINE; DECAHYDRO 6 [2 (1H TETRAZOL 5 YL)ETHYL] 3 ISOQUINOLINECARBOXYLIC ACID; DIZOCILPINE; EGLUMETAD; FELBAMATE; GLUTAMATE RECEPTOR; GLYCINE; KAINIC ACID RECEPTOR; LAMOTRIGINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHENOBARBITAL; PHENYTOIN; POSTSYNAPTIC RECEPTOR; REMACEMIDE; SODIUM CHANNEL; TOPIRAMATE; VALPROIC ACID;

ANTICONVULSANT ACTIVITY; BINDING SITE; CHANNEL GATING; DISEASE ASSOCIATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; EPILEPSY; EPILEPTIC DISCHARGE; NERVE CELL MEMBRANE STEADY POTENTIAL; NERVE CELL STIMULATION; NEUROMODULATION; NEUROTRANSMITTER RELEASE; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; RECEPTOR BLOCKING; RECEPTOR UPREGULATION; REVIEW; SODIUM CURRENT;

EID: 0031765271     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0079-6123(08)60450-1     Document Type: Review

References (60)

1. A.-S. Abdul-Ghani P.J.E. Attwell N.S. Kent H.F. Bradford M.J. Croucher D.E. Jane Anti-epilepto-genic and anticonvulsant activity of L-2-amino-4-phosphonobutyrate, a presynaptic glutamate receptor agonist Brain. Res. 755 1997 202 212
2. P.J.E. Attwell S. Kaura G. Sigala H.F. Bradford M.J. Croucher D.E. Jane J.C. Watkin Blockade of both epileptogenesis and glutamate release by (1S,3S)-ACPD, a presynaptic glutamate receptor agonist. Brain Res. 698 155–162.
3. T.I. Chao C. Alzheimer Effects of phenytoin on the persistent Na+ current of mammalian CNS neurones NeuroReport 6 1995 1778 1780
4. A.G. Chapman S.E. Smith B.S. Meldrum The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYK1 52466, in mice Epilepsy Res. 9 1991 92 96
5. A. Chimirri G. De Sarro A. De Sarro R. Gitto S. Grasso S. Quartarone M. Zappala P. Giusti V. Libri A. Constanti A.G. Chapman 1-aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: Novel AMPA receptor antagonists J. Med. Chem. 40 1997 1258 1269
6. D.A. Coulter S. Sombati R.J. DeLorenzo Topiramate effects on excitatory amino acid-mediated responses in cultured hippocampal neurons: Selective blockade of kainate currents Epilepsia 37 suppl 3 1995 S40
7. S.J. Czuczwar K.K. Borowicz Z. Kleinrok P. Tutka T. Zarnowski W.A. Turski Influence of combined treatment with NMDA and non-NMDA receptor antagonists on electroconvulsions in mice Eur. J. Pharmacol. 281 1995 327 333
8. J. Davies R.H. Evans P.L. Herrling A.W. Jones H.J. Olverman P. Pook J.C. Watkins CPP, a new potent and selective NMDA antagonist. Depression of central neuron responses, affinity for 3H-D-AP5 binding sites on brain membranes and anticonvulsant activity Brain Res. 382 1986 169 173
9. R. Dingledine C.J. Mcbain J.O. Mcnamara Excitatory amino acids receptors in epilepsy Trends Physiol. Sci. 11 1990 334 338
10. S.D. Donevan S. Yamaguchi M.A. Rogawski Non- N -methyl-D-aspartate receptor antagonism by 3- N -substituted 2,3-benzodiazepines: Relationship to anticonvulsant activity J. Pharmacol. Exp. Ther. 271 1994 25 29
11. N. Dürmüller M. Craggs B.S. Meldrum The effect of the non-NMDA receptor antagonist GYK1 52466 and NBQX and the competitive NMDA receptor antagonist D-CPPene on the development of amygdala kindling and on amygdala-kindled seizures Epilepsy Res. 17 1994 167 174
12. J.M.H. French-Mullen J.L. Barker M.A. Rogawski Calcium current block by (-)-pentobarbital, pheno-barbital, and CHEB but not (+)-pentobarbital in acutely isolated hippocampal CA1 neurons: Comparison with effects on GABA-activated CL-current J. Neurosci. 13 1993 3211 3221
13. M. Ghauri A.G. Chapman D.E. Jane B. Meldrum Anticonvulsant and proconvulsant effects of metabo-tropic glutamate receptor agonists and antagonists Epilepsia 38 suppl 3 1997 223
14. R.A. Gross D.F. Covey J.A. Ferrendelli Voltage-dependent calcium channels as targets for convulsant and anticonvulsant alkyl-substituted thiobutyrolactones J. Pharmacol. Exp. Ther. 280 1997 686 694
15. E.W. Harris A.H. Ganong D.T. Monaghan J.C. Watkins C.W. Cotman Action of 3-((+/-)-2-car-boxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP): A new and highly potent antagonist of N -methyl-D-aspartate receptors in hippocampus Brain Res. 382 1986 174 177
16. N.L. Harrison M.A. Simmonds Quantitative studies on some antagonists of N -methyl-D-aspartate in slices of rat cerebral cortex Br. J. Pharmacol. 84 1985 381 391
17. C.R. Honey Z. Miljkovic J.F. MacDonald Ketamine and phencyclidine cause a voltage-dependent block of responses to L-aspartic acid Neurosci. Lett. 61 1985 135 139
18. J.E. Huettner B.P. Bean Block of N -methyl-D-aspartate activated current by the anticonvulsant MK-801: selective binding to open channels Proc. Natl. Acad. Sci., USA 85 1988 1307 1311
19. J.W. Johnson P. Ascher Glycine potentiates the NMDA response in cultured mouse brain neurons Nature 325 1987 529 531
20. N.W. Kleckner R.D. Dingledine Requirement for glycine in activation of NMDA receptors expressed in Xenopus oocytes Science 241 1988 835 837
21. M.J. Leach C.M. Marden A.A. Miller Pharmacological studies on lamotrigine, a novel potential antieli-peptic drug Epilepsia 27 1986 490 497
22. Lees M.J., Leach 1993 Studies on the mechamism of action of the novel anticonvulsant lamotrigine (Lamictal) using primary neuroglial cultures from rat cortex. Brain Res. 190–199.
23. G.Y.L. Ko L.M. Brown-Croyts T.J. Teyler The effects of anticonvulsant drugs on NMDA-EPSP, AMPA-EPSP, and GABA-IPSP in the rat hippocampus Brain Res. Bull. 42 1997 297 302
24. C.-C. Kuo B.P. Bean Slow binding of phenytoin to inactivated sodium channels in rat hippocampal neurons Mol. Pharmacol. 46 1994 716 725
25. C.-C Kuo R.-S Chen L. Lu R.-C. Chen Carbamazepine inhibition of neuronal Na currents: Quantitative distinction from phenytoin and possible therapeutic implications Mol. Pharmacol. 51 1997 1077 1083
26. W. Löscher D. Hönack Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYK1 52466 on different seizure types in mice: Comparison with diazepam and interactions with flumazenil Br. J. Pharmacol. 113 1994 1349 1357
27. W. Löscher C. Rundfeldt D. Hönack Low doses of NMDA receptor antagonists synergistically increase the anticonvulsant effect of the AMPA receptor antagonist NBQX in the kindling model of epilepsy Eur. J. Neurosci. 5 1993 1545 1550
28. D. Martin D. Lodge Ketamine acts as a non-competitive N -methyl-D-aspartate antagonist on frog spinal cord in vitro Neuropharmacology 24 1985 999 1003
29. N.F.N. Matsuki R.E. Quandt Ten Eick J.Z. Yeh Characterization of the block of sodium channels by phenytoin in mouse neuroblastoma cells J. Pharmacol. Exp. Ther. 228 1984 523 530
30. R.T. McCabe B.M. Olivera E. Jimenez L.J. Cruz L.M. Zhou H.S. White Anticonvulsant profile on Conantokin-R: A novel and selective antagonist at the NMDAR1–1b/NR2b subunit Epilepsia 38 suppl 3 1997 S230
31. R.T. McCabe C.G. Wasterlain N. Kucharczyk R.D. Sofia J.R. Vogel Evidence for anticonvulsant and neuroprotectant action of felbamate mediated by strychnine-insensitive glycine receptors J. Pharmacol. Exp. Ther. 264 1993 1248 1252
32. M.J. McLean R.L. Macdonald Multiple actions of phenytoin on mouse spinal cord neurons in cell cultures J. Pharmacol. Exp. Ther. 227 1983 779 789
33. M.L. McLean R.L. Macdonald Carbamazepine and 10.11-epoxycarbamazeoine produce use- and voltage-dependent limitation of rapidly firing action potentials of mouse central neurons in cell culture J. Pharmacol. Exp. Ther. 238 1986 727 732
34. D.T. Monaghan R.J. Bridges C.W. Cotman The excitatory amino acid receptors: Their classes, pharmacology, and distinct properties in the function of the central nervous system Annu. Rev. Pharmacol. Toxicol. 29 1989 365 402
35. J.A. Monn M.J. Valli S.M. Massey R.A. Wright C.R. Salhoff B.G. Johnson T. Howe C.A. Alt G.A. Rhodes R.L. Robey K.R. Griffey J.P. Tizzano M.J. Kallmann D.R. Helton D.D. Schoepp Design, synthesis, and pharmacological characterization of (+)-2-amino-biocyclo(3.1.0.)hexane-2,6-dicarboxylic acid (LY354740): A potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possesing anticonvulsant and anxiolytic properties J. Med. Chem. 40 1997 528 537
36. J.E. Piña-Garza M.J. McLean Different effects of topiramate and phenytoin on mouse seizures and responses of cultured neurons to excitatory amino acids Epilepsia 37 suppl 5 1996 S26
37. R.J. Porter Mechanisms of action of new antiepileptic drugs Epilepsia 30 suppl. 1 1989 S29 S34
38. J.M. Rho S.D. Donevan M.A. Rogawski Mechanism of action of the anticonvulsant felbamate: Opposing effects on N -methyl-D-aspartate and γ-aminobutyric acid a receptors Ann. Neurol. 35 1994 229 234
39. M.A. Rogawski R. Porter Antiepileptic drugs: Pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds Pharmacol. Rev. 42 1990 223 286
40. M.M. Segel Endogenous bursts underlie seizurelike activity insolitary excitatory hippocampal neurons in micro-cultures J. Neurphysiol. 72 1994 1874 1884
41. M.M. Segal Douglas A.F. Late sodium channel openings underlying epileptiform activity are preferentially diminished by the anticonvulsant phenytoin. J. Neurophysiol. 77 3021–3034
42. R.D. Sofia R. Gordon M. Gels W. Diamantis Comparative effects of felbamate and other compounds on N -methyl-D-aspartic acid-induced convulsions and lethality in mice Pharmacol. Res. 29 1994 139 144
43. S. Sveinbjornsdottir J.W.A.S. Sander D. Upton P.J. Thompson P.N. Patsalos D. Hirt M. Emre D. Lowe J.S. Duncan The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy Epilepsy Res 16 1993 165 174
44. L. Severt D.A. Coulter S. Sombati J. DeLorenzo Topiramate selectively blocks kainate currents in cultured hippocampal neurons Epilepsia 36 suppl 4 1995 S38
45. R.S. Sohn J.A. Ferendelli Anticonvulsant drug mechanisms: Phenytoin, phenobarbital and anf ethosuximide and calcium flux in isolated presynaptic endings Arch. Neurol. 33 1976 626 629
46. A. Stefani F. Spadoni Sinicalchi A. G. Bernardi Lamotrigine inhibits Ca+ currents in cortical neurons; Functional implications Eur. J. Pharmacol. 307 1996 113 116
47. E. Taubøll O.P. Ottersen L. Gjerstad The progesterone metabolite 5α-pregnan-3α.ol-20-one reduces K+-induced GABA and glutamate release: A semiquantitative immunocytochemical study Brain. Res. 623 1993 329 333
48. C.P. Taylor Na+ currents that fail to inactivate Trends Neurosci. 16 1993 455 460
49. C.P. Taylor B.S. Meldrum Na+ channels as targets for neuroprotective drugs Trends Pharmacol. Sci. 16 1995 309 316
50. C.P. Taylor L.S. Narasimhan Sodium channels and therapy of central nervous system diseases Adv. Pharmacol. 39 1997 47 98
51. P.C. Waldmeier P. Martin K. Stocklin C. Portet M. Schmutz Effect of carbamazepine, oxcarbazepine and lamotrigine on the indcrease in extracellular glutamate elicited by veratridine in rat cortex and striatum Naunyn-Schmiedeberǵs Arch. Pharmacol. 354 1996 164 172
52. J.K. Wamsley R.D. Sofia R.L.M. Faull N. Narang T. Ary X-D. Gan R.T. McCabe Felbamate: Interaction with glycine receptors in human cerebral cortex Proc. West. Pharmacol. Soc. 37 1994 81 83
53. H.S. White W.L. Harmsworth R.D. Sofia H.H. Wolf Felbamate modulates the strychnine-insensitive glycine receptor Epilepsy Res. 20 1995 41 48
54. K. Williams C. Roman P.B. Molinoff Effects of polyamines on the binding of [3H]MK-801 to the N -methyl-D-aspartate receptor: Pharmacological evidence for the existence of a polyamine recognition site Mol. Pharmacol. 36 1989 575 581
55. M. Willow T. Gonoi W.A. Caterall Voltage clamp analysis of the inhibitory actions of diphenylhydantoin and carbamazepine on voltage-sensitive sodium channels in neuroblastoma cells Mol. Pharmacol. 27 1985 548 549
56. E.H.F. Wong J.A. Kemp Sites for antagonism on the N -methyl-D-aspartate receptor channel complex Annu. Rev. Pharmacol. Toxicol. 31 1991 401 425
57. J.T. Wroblewski W. Danysz Modulation of glutamate receptors: Molecular mechanisms and functional implications Annu. Rev. Pharmacol. Toxicol. 29 1989 441 474
58. X. Xie B. Lancaster Y. Peakman J. Garthwaite Interaction of the antiepileptic drug lamotrigine with the recombinant rat brain type IIA Na+ channels and with native Na+ channels in rat hippocampal neurones Pfluegers Arch. 430 1995 437 446
59. S. Yamaguchi S.D. Donevan M.A. Rogawski Anticonvulsant activity of AMPA/kainate antagonists: Comparison of GYK1 52466 and NBQX in maximal electroshock and chemoconvulsant seizure models Epilepsy Res. 15 1993 179 184
60. T. Zarnowski Z. Kleinrok W.A. Turski S.J. Czuczwar Dihydroxy-6-nitro-7-sulfamoylbenzo[F]quinoxa-line enhances the protective activity of common antiepileptic drugs against maximal electroshock-induced seizures in mice Neuropharmacology 32 1993 895 900